WYC-209 is primarily utilized in the field of cancer research due to its potential as a therapeutic agent. It has shown promise in targeting specific pathways involved in tumor growth and proliferation, making it a subject of interest in preclinical studies. Researchers are exploring its efficacy in inhibiting cancer cell survival and enhancing the effectiveness of existing treatments. Additionally, WYC-209 is being investigated for its role in reducing drug resistance in certain types of cancers, offering a potential avenue for improving patient outcomes. Its application extends to studying cellular mechanisms and developing novel strategies for cancer therapy.